September 16, 2014
Purdue startup commercializing innovation to reduce neurotoxin that damages nerve cells, triggers pain
A Purdue startup is commercializing a technology that could reduce the symptoms and pain of neurological disease and injury, including multiple sclerosis, neuropathic pain and Parkinson's disease.